ARTICLE | Politics, Policy & Law

Cancer KOLs urge Biden to name Woodcock permanent FDA commissioner

February 11, 2021 9:54 PM UTC

Acting FDA Commissioner Janet Woodcock has picked up a powerful endorsement in a public campaign for President Joe Biden to delete the “acting” part of her title. Nobel laureate James Allison and Mikael Dolsten, CSO of Pfizer, joined a virtual Who’s Who of 95 cancer researchers, clinicians, and advocates in signing a public letter urging Biden to nominate Woodcock as FDA commissioner.

Allison and Dolsten served as members of NCI’s Cancer Moonshot Blue Ribbon Panel that advised an initiative Biden led during the Obama administration. Dolsten’s position at Pfizer Inc. (NYSE:PFE) is not listed on the letter which identifies him as “professor” and a member of the Moonshot panel. ...